Investigation into the Sale of Surmodics to GTCR Raises Concerns
Wednesday, 29 May 2024, 11:36
Investigation of Surmodics Sale to GTCR
The Monsey firm of Wohl & Fruchter is conducting a review of the acquisition of Surmodics by GTCR. This investigation aims to assess the fairness of the sale and its impact on stakeholders.
Concerns Raised
Inquiries have arisen regarding the terms and conditions of the transaction, prompting further examination by legal experts.
Investors should monitor the progress of the investigation to understand the implications for Surmodics' shareholders.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.